Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population.

Aggarwal NT, Bienias JL, Bennett DA, Wilson RS, Morris MC, Schneider JA, Shah RC, Evans DA.

Neuroepidemiology. 2006;26(3):140-6. Epub 2006 Feb 21.

PMID:
16493200
2.

Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.

Evans DA, Bennett DA, Wilson RS, Bienias JL, Morris MC, Scherr PA, Hebert LE, Aggarwal N, Beckett LA, Joglekar R, Berry-Kravis E, Schneider J.

Arch Neurol. 2003 Feb;60(2):185-9.

PMID:
12580702
3.

The influence of smoking on the risk of Alzheimer's disease.

Merchant C, Tang MX, Albert S, Manly J, Stern Y, Mayeux R.

Neurology. 1999 Apr 22;52(7):1408-12.

PMID:
10227626
4.

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA.

Neurocase. 2005 Feb;11(1):3-7.

PMID:
15804918
5.

Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.

Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM.

Neurology. 2007 Sep 4;69(10):998-1005.

PMID:
17785668
6.

The cross-sectional association between blood pressure and Alzheimer's disease in a biracial community population of older persons.

Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, Evans DA.

J Gerontol A Biol Sci Med Sci. 2000 Mar;55(3):M130-6.

PMID:
10795724
7.

Cognitive activity and incident AD in a population-based sample of older persons.

Wilson RS, Bennett DA, Bienias JL, Aggarwal NT, Mendes De Leon CF, Morris MC, Schneider JA, Evans DA.

Neurology. 2002 Dec 24;59(12):1910-4.

PMID:
12499482
8.

Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent.

Sahota A, Yang M, Gao S, Hui SL, Baiyewu O, Gureje O, Oluwole S, Ogunniyi A, Hall KS, Hendrie HC.

Ann Neurol. 1997 Oct;42(4):659-61.

PMID:
9382479
9.

Comparison of Alzheimer's disease risk factors in white and African American families.

Bachman DL, Green RC, Benke KS, Cupples LA, Farrer LA; MIRAGE Study Group.

Neurology. 2003 Apr 22;60(8):1372-4.

PMID:
12707449
10.

Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.

Hendrie HC, Hall KS, Hui S, Unverzagt FW, Yu CE, Lahiri DK, Sahota A, Farlow M, Musick B, Class CA, et al.

Ann Neurol. 1995 Jan;37(1):118-20.

PMID:
7818244
11.

The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults.

Blazer DG, Fillenbaum G, Burchett B.

J Gerontol A Biol Sci Med Sci. 2001 Dec;56(12):M785-9.

PMID:
11723155
12.

Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study.

Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, van Duijn CM, Breteler MM.

Lancet. 1998 Jun 20;351(9119):1840-3.

PMID:
9652667
13.

Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.

van Duijn CM, Havekes LM, Van Broeckhoven C, de Knijff P, Hofman A.

BMJ. 1995 Mar 11;310(6980):627-31.

14.

The allele interaction between apolipoprotein epsilon2 and epsilon4 in Taiwanese Alzheimer's disease patients.

Lung FW, Yen YC, Chou LJ, Hong CJ, Wu CK.

Acta Psychiatr Scand. 2005 Jan;111(1):38-43.

PMID:
15636592
15.

Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset.

Duara R, Barker WW, Lopez-Alberola R, Loewenstein DA, Grau LB, Gilchrist D, Sevush S, St George-Hyslop S.

Neurology. 1996 Jun;46(6):1575-9.

PMID:
8649551
16.

Genetic factors for the development of Alzheimer disease in the Cherokee Indian.

Rosenberg RN, Richter RW, Risser RC, Taubman K, Prado-Farmer I, Ebalo E, Posey J, Kingfisher D, Dean D, Weiner MF, Svetlik D, Adams P, Honig LS, Cullum CM, Schaefer FV, Schellenberg GD.

Arch Neurol. 1996 Oct;53(10):997-1000.

PMID:
8859062
17.

Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?

Guo Z, Fratiglioni L, Viitanen M, Lannfelt L, Basun H, Fastbom J, Winblad B.

Am J Epidemiol. 2001 Feb 1;153(3):225-31.

PMID:
11157409
18.

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL.

Neurology. 2003 Jan 28;60(2):246-52.

PMID:
12552039
20.

Proneness to psychological distress and risk of Alzheimer disease in a biracial community.

Wilson RS, Barnes LL, Bennett DA, Li Y, Bienias JL, Mendes de Leon CF, Evans DA.

Neurology. 2005 Jan 25;64(2):380-2.

PMID:
15668449

Supplemental Content

Support Center